Abstract
The orofacial region is critical for survival due to its role in eating and drinking, identity and self-esteem, and communication and expressions of emotion. Orofacial pain is comparatively less tolerated than pain in other body areas due to its disproportionately large representation in the cerebral cortex. The individual with severe orofacial pain can therefore be at significant risk of deficient nutritional intake, dehydration, and withdrawal from essential social interactions. Chronic pain is a multidimensional experience, with sensory-discriminative, emotional, cultural, and cognitive components. It is influenced by environment, hormonal, and mood fluctuations; neurologic and inflammatory changes; as well as cognitive and physiologic memory of previous encounters with pain. The successful treatment of pain requires thorough assessment of the cause and character of the pain, its underlying pathophysiology, and contribution of psychological, social, spiritual, and practical issues. Elucidating the qualities and characteristics of orofacial pain disorders and syndromes is essential for successful selection of therapies, according to various levels of evidence and based on rigorous research-based classification and diagnostic criteria. This chapter provides a concise and complete resource for dosing of the various classes and of pain medications and adjunctive medications in the treatment of orofacial pain across the age range from neonates to geriatric patients. Furthermore, this chapter addresses the unique physiology of each age group, the important alterations in pharmacokinetics which occur at various ages and with common comorbidities, and the importance of synergistic multimodal polypharmacy/analgesia. Successful management of orofacial pain must include not only pharmacologic interventions but also adequate follow-up with verbal and written education of the patient, family, and caregivers to assure compliance and decrease the incidence of adverse effects. Based on the complexity and chronicity of pain, its management may also require important interdisciplinary team members including nursing, social workers, pharmacists, chaplains, physiotherapists, occupational therapists, and stage of life specialists. Integration of cognitive behavioral therapies, physical medicine, and rehabilitation approaches, together with evidence-based alternative and mind–body approaches, improves patient satisfaction and well-being, decreases pain medication requirements, and lessens side effects compared to the use of medications alone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Maizes V, et al. Integrative medicine and patient centered care. Explore (NY). 2009;5(5):277–89.
Oelesen J et al. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders 2nd Edn. Cephalgia 2004;24(1):8–152
de Leeuw R, The American Academy of Orofacial Pain, et al. Orofacial pain: guidelines for assessment, diagnosis, and management. 4th ed. Chicago: Quintessence Publishing Company, Inc.; 2008.
Elvir-Lazo OL. Postoperative pain management after ambulatory surgery: role of multimodal analgesia. Anesthesiol Clinc. 2010;28(2):217–24.
MacGregor AJ. The heritability of pain in humans. In: Mogil JS, editor. The genetics of pain, Progress in pain research and management, vol. 28. Seattle: IASP Press; 2004. p. 151–70.
Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–52.
Kusumi M, Araki H, Ijiri T, et al. Serotonin 2C receptor gene Cys23Ser polymorphism: a candidate genetic risk factor of migraine with aura in Japanese population. Acta Neurol Scand. 2004;109:407–9.
Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet. 2004;114:225–35.
Violon A, Giugea D. Familial models for chronic pain. Pain. 1984;18:199–203.
Edwards PW, Zeichner A, Kuczmierczyk AR, Boczkowski J. Familial pain models: the relationship between family history of pain and current pain experience. Pain. 1985;21:379–84.
Chun LJ, Tong MJ, Busuttil R, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009;43(4):342–9.
Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity—where do we go from here? Expert Opin Drug Saf. 2007;6(4):341–55.
Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology. 1995;22(3):767–73.
Mehta S. Pediatric Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India Malnutrition and drugs: clinical implications. Dev Pharmacol Ther. 1990;15(3–4):159–65.
Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008;4(1):2–6.
Scanzello CR, Moskowitz NK, Gibofsky JD. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Curr Pain Headache Rep. 2007;11:415–22.
Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–94.
Kalso E, Allan L, Dellemijn PL, Faura CC, Ilias WK, Jensen TS, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain. 2003;7:381–6.
Kroenke K, Dregs EE, et al. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiat. 2009;31:206–19.
Gallagher RM, Rosenthal LJ. Chronic pain and opiates: balancing pain control and risks in long-term opioid treatment. Arch Phys Med Rehabil. 2008;89(3 Suppl 1):S77–82.
Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging. 2008;3(3):421–30.
Kirsh KL, Fishman SM. Multimodal approaches to optimize outcomes of chronic opioid therapy in the management of chronic pain. Pain Med. 2011;S1:S1–11.
McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg. 1999;89:985–8.
Lin TF, Yeh YC, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anesth. 2009;102(1):117–22.
Sigtermans MJ, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. Pain. 2009;145:304–11.
Anand KJ. Pain, plasticity, and premature birth: a prescription for permanent suffering? Nat Med. 2000;6:971–3.
Grunau RE. Long-term consequences of pain in human neonates. In: Anand KJS, Stevens BJ, McGrath PJ, editors. Pain in neonates. 2nd ed. New York, NY: Elsevier; 2000. p. 55–76.
Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet. 1997;349:599–603.
Reynolds ML, Fitzgerald M. Long-term sensory hyperinnervation following neonatal skin wounds. J Comp Neurol. 1995;358:487–98.
Ruda MA, Ling QD, Hohmann AG, Peng YB, Tachibana T. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science. 2000;289:628–31.
Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, van Suijlekom SLW, Passchier J, van der Wouden JC. Chronic pain among children and adolescents: physician consultation and medication use. Clin J Pain. 2000;16:229–35.
Campo JV, Di LC, Chiappetta L, et al. Adult outcomes of pediatric recurrent abdominal pain: do they just grow out of it? Pediatrics. 2001;108:E1.
Lee BH, Scharff L, Sethna NF, et al. Physical therapy and cognitive-behavioral treatment for complex regional pain syndromes. J Pediatr. 2002;141:135–40.
Jones HE, Martin PR, Heil SH. Treatment of opioid dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35(3):245–59.
Kandall SR, Albin S, et al. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev. 1977;1(2):159–69.
Acknowledgement
None declared.
Conflict of Interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland 2014
About this chapter
Cite this chapter
Laughlin, I., Hickey, A.H. (2014). Analgesics and Adjuvants for the Management of Orofacial Pain Across Age Groups. In: Vadivelu, N., Vadivelu, A., Kaye, A. (eds) Orofacial Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-01875-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-01875-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-01874-4
Online ISBN: 978-3-319-01875-1
eBook Packages: MedicineMedicine (R0)